|
US1005853A
(en)
|
1911-06-24 |
1911-10-17 |
Louis B Lewis |
Educational toy.
|
|
US3686412A
(en)
|
1965-03-25 |
1972-08-22 |
Colin Fitzmaurice |
Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
|
|
GB1144905A
(en)
|
1965-03-25 |
1969-03-12 |
Fisons Pharmaceuticals Ltd |
Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
|
|
GB1242211A
(en)
|
1967-08-08 |
1971-08-11 |
Fisons Pharmaceuticals Ltd |
Pharmaceutical composition
|
|
US3957965A
(en)
*
|
1967-08-08 |
1976-05-18 |
Fisons Limited |
Sodium chromoglycate inhalation medicament
|
|
GB1257162A
(enExample)
|
1968-02-16 |
1971-12-15 |
|
|
|
US4405598A
(en)
|
1976-01-30 |
1983-09-20 |
Fisons, Limited |
Composition for treating asthma
|
|
US4120285A
(en)
|
1976-11-01 |
1978-10-17 |
Owens-Illinois, Inc. |
Modular tubular solar energy collector apparatus
|
|
DE3104294A1
(de)
|
1981-02-07 |
1982-08-19 |
Hoechst Ag, 6000 Frankfurt |
Substituierte diazaspirodecane, ihre herstellung, ihre verwendung als stabilisatoren fuer organische polymere, sowie die so stabilisierten polymeren
|
|
US4429545A
(en)
|
1981-08-03 |
1984-02-07 |
Ocean & Atmospheric Science, Inc. |
Solar heating system
|
|
BE897058A
(fr)
|
1982-06-25 |
1983-12-16 |
Sandoz Sa |
Utilisation d'un derive du spiro-succinimide dans le traitement de la demence du type alzheimer
|
|
US4996296A
(en)
|
1983-07-27 |
1991-02-26 |
Yeda Research & Development Co., Ltd. |
Cromolyn binding protein in highly purifed form, and methods for the isolation thereof
|
|
US4919915A
(en)
*
|
1987-03-03 |
1990-04-24 |
Paul Averback |
Method for detecting the ability to prevent red-to-green congophilic birefringence
|
|
US5231170A
(en)
*
|
1986-08-27 |
1993-07-27 |
Paul Averback |
Antibodies to dense microspheres
|
|
WO1990013327A1
(en)
|
1989-04-28 |
1990-11-15 |
Riker Laboratories, Inc. |
Dry powder inhalation device
|
|
US5376386A
(en)
|
1990-01-24 |
1994-12-27 |
British Technology Group Limited |
Aerosol carriers
|
|
DE4405387A1
(de)
|
1994-02-19 |
1995-08-24 |
Hoechst Ag |
Verfahren zur Herstellung von Polyalkyl-1-oxa-diazaspirodecan-Verbindungen
|
|
US6168776B1
(en)
|
1994-07-19 |
2001-01-02 |
University Of Pittsburgh |
Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
|
|
CA2174583A1
(en)
|
1995-05-05 |
1996-11-06 |
Alexander Chucholowski |
Sulfuric acid esters of sugar alcohols
|
|
US6026809A
(en)
|
1996-01-25 |
2000-02-22 |
Microdose Technologies, Inc. |
Inhalation device
|
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
|
WO1999016421A1
(en)
*
|
1997-09-29 |
1999-04-08 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
|
US5904937A
(en)
|
1997-10-03 |
1999-05-18 |
Fmc Corporation |
Taste masked pharmaceutical compositions
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
DK1083952T3
(da)
|
1998-06-12 |
2006-04-24 |
Microdose Technologies Inc |
Apparat til uddeling af medicinalvarer og medikamenter
|
|
US6197963B1
(en)
|
1998-08-13 |
2001-03-06 |
The Trustees Of The University Of Pennsylvania |
Non-peptide peptidomimetics
|
|
HU226164B1
(en)
*
|
1998-11-13 |
2008-05-28 |
Jagotec Ag |
Use of magnesium stearate in dry powder compositions suitable for inhalation and compositions suitable for inhalation
|
|
ATE252386T1
(de)
|
1998-12-24 |
2003-11-15 |
Janssen Pharmaceutica Nv |
Galantamin-zusammensetzung mit gesteuerter freisetzung
|
|
JP2001151673A
(ja)
|
1999-09-06 |
2001-06-05 |
Nikken Chem Co Ltd |
吸入用粉末製剤の製造方法
|
|
US20020107173A1
(en)
*
|
1999-11-04 |
2002-08-08 |
Lawrence Friedhoff |
Method of treating amyloid beta precursor disorders
|
|
US20020009491A1
(en)
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
|
ES2248283T3
(es)
|
2000-02-21 |
2006-03-16 |
Pharmexa A/S |
Nuevo procedimiento para reducir los niveles de amiloide.
|
|
CA2406383A1
(en)
|
2000-04-13 |
2001-10-25 |
Mayo Foundation For Medical Education And Research |
A.beta.42 lowering agents
|
|
US20080021085A1
(en)
|
2000-04-13 |
2008-01-24 |
Mayo Foundation For Medical Education And Research |
Method of reducing abeta42 and treating diseases
|
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
|
AR035642A1
(es)
|
2000-05-26 |
2004-06-23 |
Pharmacia Corp |
Uso de una composicion de celecoxib para el alivio rapido del dolor
|
|
US20020016359A1
(en)
|
2000-06-29 |
2002-02-07 |
Hellberg Mark R. |
Compositions and methods of treating neurodegenerative diseases
|
|
US8519005B2
(en)
|
2000-07-27 |
2013-08-27 |
Thomas N. Thomas |
Compositions and methods to prevent toxicity of antiinflammatory agents and enhance their efficacy
|
|
FR2815030A1
(fr)
|
2000-10-05 |
2002-04-12 |
Lipha |
Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant et leur utilisation pour la preparation de medicaments
|
|
US6511960B2
(en)
|
2001-01-05 |
2003-01-28 |
Alphamed Pharmaceuticals Corp |
Cromolyn for eye and ear infections
|
|
ATE349446T1
(de)
|
2001-04-23 |
2007-01-15 |
Univ Pennsylvania |
Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel
|
|
US20040259952A1
(en)
|
2001-11-29 |
2004-12-23 |
Richat Abbas |
Formulations for oral administration of cromolyn sodium
|
|
ES2337350T3
(es)
|
2002-05-10 |
2010-04-23 |
Oriel Therapeutics, Inc. |
Inhalador de polvo seco para uso con medios de dispensacion activados por polimeros piezoelectricos y envases de blisteres asociado que comprende un material polimerico piezoelectrico.
|
|
EP1601380A1
(en)
|
2003-02-13 |
2005-12-07 |
Licentia OY |
Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia
|
|
US8163734B2
(en)
|
2003-02-13 |
2012-04-24 |
Perttu J. Lindsberg |
Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses
|
|
US20040223918A1
(en)
|
2003-05-07 |
2004-11-11 |
Chrysalis Technologies Incorporated |
Aerosolization of cromolyn sodium using a capillary aerosol generator
|
|
GB0321607D0
(en)
|
2003-09-15 |
2003-10-15 |
Vectura Ltd |
Manufacture of pharmaceutical compositions
|
|
JP4471340B2
(ja)
|
2003-10-07 |
2010-06-02 |
芦森工業株式会社 |
バックル装置
|
|
EP1686960A4
(en)
*
|
2003-10-28 |
2007-03-07 |
Glaxo Group Ltd |
INHALABLE PHARMACEUTICAL PREPARATIONS EMPLOYING LACTOSE ANHYDRATE, AND METHODS OF ADMINISTERING SAID PREPARATIONS
|
|
GB0326632D0
(en)
*
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
|
DE10355559A1
(de)
|
2003-11-21 |
2005-06-23 |
Orthogen Ag |
Transskin
|
|
US8088935B2
(en)
|
2003-12-23 |
2012-01-03 |
Ironwood Pharmaceuticals, Inc. |
Compounds and methods for the treatment of asthma
|
|
US20070093457A1
(en)
|
2004-02-11 |
2007-04-26 |
Nadir Arber |
Compositions for treatment of cancer and inflammation with curcumin and at least one nsaid
|
|
US20050182044A1
(en)
|
2004-02-17 |
2005-08-18 |
Bruinsma Gosse B. |
Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
|
|
WO2006001877A2
(en)
|
2004-04-13 |
2006-01-05 |
Myriad Genetics, Inc. |
Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
|
|
BRPI0510119A
(pt)
|
2004-04-23 |
2007-09-25 |
Cydex Inc |
formulação para dpi contendo sulfoaquil éter de ciclodextrina
|
|
ES2339790T3
(es)
|
2004-08-30 |
2010-05-25 |
Seo Hong Yoo |
Efecto neuroprotector de udca solubilizado en modelo isquemico focal.
|
|
KR101358078B1
(ko)
|
2004-11-01 |
2014-02-06 |
주식회사 유스팜인터내셔널 |
근위축성 측삭 경화증의 신경퇴행을 감소시키기 위한 방법및 조성물
|
|
RU2007143302A
(ru)
|
2005-04-22 |
2009-05-27 |
Дженентек, Инк. (Us) |
Способ лечения деменции или болезни альцгеймера антителами к cd20
|
|
AU2006251832A1
(en)
|
2005-05-27 |
2006-11-30 |
Queen's University At Kingston |
Treatment of protein folding disorders
|
|
JP2009519972A
(ja)
|
2005-12-15 |
2009-05-21 |
アキュスフィア， インコーポレイテッド |
粒子ベースの経肺投与または経鼻投与用製薬の製造方法
|
|
US8263645B2
(en)
|
2006-02-03 |
2012-09-11 |
Pari Pharma Gmbh |
Disodium cromoglycate compositions and methods for administering same
|
|
AR059356A1
(es)
|
2006-02-14 |
2008-03-26 |
Astrazeneca Ab |
Nuevos radioligandos
|
|
EP1994011B1
(en)
|
2006-03-06 |
2010-10-13 |
RaQualia Pharma Inc |
Sulfonyl benzimidazole derivatives
|
|
EA200801967A1
(ru)
|
2006-03-09 |
2009-04-28 |
Ворэта Фармэсьютиклз Инк. |
Дозированная лекарственная форма на основе циклогексанового полиола (варианты), способ ее получения, способ лечения болезни альцгеймера с ее помощью и циклогексановый полиол в качестве средства при изготовлении лекарственного средства
|
|
WO2008118122A2
(en)
|
2006-05-08 |
2008-10-02 |
Molecular Neuroimaging, Llc |
Compounds and amyloid probes thereof for therapeutic and imaging uses
|
|
US8445437B2
(en)
|
2006-07-27 |
2013-05-21 |
The Brigham And Women's Hospital, Inc. |
Treatment and prevention of cardiovascular disease using mast cell stabilizers
|
|
US20100173960A1
(en)
|
2006-09-21 |
2010-07-08 |
Antonio Cruz |
The Combination of a Cyclohexanehexol and a NSAID for the Treatment of Neurodegenerative Diseases
|
|
WO2008061373A1
(en)
|
2006-11-24 |
2008-05-29 |
Waratah Pharmaceuticals Inc. |
Combination treatments for alzheimer's disease and similar diseases
|
|
DK2142513T3
(da)
|
2007-04-18 |
2014-06-10 |
Probiodrug Ag |
Nitrovinyl-diamin-derivater som glutaminyl-cyclase-inhibitorer
|
|
CN101970000A
(zh)
|
2007-04-18 |
2011-02-09 |
杨森阿尔茨海默氏症免疫治疗公司 |
脑淀粉样血管病的预防和治疗
|
|
WO2008134618A2
(en)
|
2007-04-27 |
2008-11-06 |
The General Hospital Corporation |
Novel imaging tracers for early detection and treatment of amyloid plaques caused by alzheimer's disease and related disorders
|
|
EP2173380A4
(en)
|
2007-07-13 |
2011-08-31 |
Abbott Biotech Ltd |
METHOD AND COMPOSITIONS FOR PULMONARY ADMINISTRATION OF A TNFa HEMMER
|
|
GB0714134D0
(en)
|
2007-07-19 |
2007-08-29 |
Norton Healthcare Ltd |
Dry-powder medicament
|
|
DK2182983T3
(da)
|
2007-07-27 |
2014-07-14 |
Janssen Alzheimer Immunotherap |
Behandling af amyloidogene sygdomme med humaniserede anti-abeta antistoffer
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
CA2718035C
(en)
|
2008-03-21 |
2017-10-24 |
The General Hospital Corporation |
Inositol derivatives for the detection and treatment of alzheimer' s disease and related disorders
|
|
ES2764480T3
(es)
|
2008-04-29 |
2020-06-03 |
Impact Coatings Ab |
Composiciones de combinación para tratar la enfermedad de Alzheimer y trastornos relacionados con zonisamida y acamprosato
|
|
KR20110117146A
(ko)
*
|
2009-01-22 |
2011-10-26 |
라퀄리아 파마 인코포레이티드 |
Ｃｂ2 수용체 효능활성이 있는 ｎ-치환 포화 헤테로사이클릭 술폰 화합물
|
|
US8381454B1
(en)
|
2009-01-23 |
2013-02-26 |
Markus R. Robinson |
Segmented, elongated, expandable, 4-season, double-walled, low-cost, rigid extruded plastic panel structures
|
|
CN105061376A
(zh)
*
|
2009-01-29 |
2015-11-18 |
通用医疗公司 |
色甘酸衍生物以及成像和治疗的相关方法
|
|
US9925282B2
(en)
|
2009-01-29 |
2018-03-27 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
|
EP2810652A3
(en)
|
2009-03-05 |
2015-03-11 |
AbbVie Inc. |
IL-17 binding proteins
|
|
CN102421775A
(zh)
|
2009-03-11 |
2012-04-18 |
普莱希科公司 |
抑制Raf激酶的吡咯并[2，3-b]吡啶衍生物
|
|
AU2010225923B2
(en)
*
|
2009-03-16 |
2016-10-27 |
Ipintl, Llc |
Treating Alzheimer's disease and osteoporosis and reducing aging
|
|
EP2248517B1
(en)
|
2009-05-08 |
2014-03-26 |
PARI Pharma GmbH |
Concentrated mast cell stabilizing pharmaceutical formulations
|
|
JP2013501046A
(ja)
|
2009-08-06 |
2013-01-10 |
ニューラルタス ファーマシューティカルズ， インコーポレイテッド |
マクロファージ関連障害の処置
|
|
US20120175082A1
(en)
|
2009-09-14 |
2012-07-12 |
Kmetovicz Ronald E |
Solar heat pipe heat exchanger
|
|
KR20180094126A
(ko)
|
2009-09-24 |
2018-08-22 |
위스타 레보레이토리스 리미티드 |
결정질 메틸티오니늄 클로라이드（메틸렌 블루） 수화물
|
|
EP2322163A1
(en)
|
2009-11-03 |
2011-05-18 |
Pharnext |
New therapeutics approaches for treating alzheimer disease
|
|
US20110262442A1
(en)
|
2009-11-06 |
2011-10-27 |
Adenios, Inc. |
Compositions for treating cns disorders
|
|
JP5854476B2
(ja)
|
2009-11-30 |
2016-02-09 |
アデア ファーマスーティカルズ，インコーポレイテッド |
圧縮性コーティングで被覆された医薬組成物及び錠剤並びに製造方法
|
|
US8455755B2
(en)
|
2009-12-07 |
2013-06-04 |
Electrotherm |
Concentrated photovoltaic and thermal solar energy collector
|
|
EP2377860A1
(en)
|
2010-04-16 |
2011-10-19 |
AC Immune S.A. |
Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
|
|
WO2011136754A1
(en)
|
2010-04-26 |
2011-11-03 |
Mahmut Bilgic |
A medicament developed for the treatment of respiratory diseases
|
|
RU2580890C2
(ru)
*
|
2010-09-30 |
2016-04-10 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Применение стеарата магния в составах сухого порошка для ингаляции
|
|
US20120121656A1
(en)
|
2010-11-15 |
2012-05-17 |
Revalesio Corporation |
Methods and compositions for protecting against neurotoxicity of a neurotoxic agent, and improving motor coordination associated with a neurodegenerative condition or disease
|
|
SG192666A1
(en)
|
2011-02-11 |
2013-09-30 |
Wista Lab Ltd |
Phenothiazine diaminium salts and their use
|
|
BR112014029442A2
(pt)
*
|
2012-05-25 |
2017-06-27 |
Xlear Inc |
composições antimucosas à base de xilitol e métodos e composições relacionados
|
|
WO2014065275A1
(ja)
|
2012-10-23 |
2014-05-01 |
国立大学法人福井大学 |
腫瘍融解症候群の治療薬及び予防薬
|
|
EP2911664B1
(en)
|
2012-10-25 |
2019-05-08 |
The General Hospital Corporation |
Combination therapies for the treatment of alzheimer's disease and related disorders
|
|
US10058530B2
(en)
|
2012-10-25 |
2018-08-28 |
The General Hospital Corporation |
Combination therapies for the treatment of Alzheimer's disease and related disorders
|
|
HK1218050A1
(zh)
*
|
2013-05-23 |
2017-02-03 |
Aztherapies, Inc |
用於递送色甘酸的方法
|
|
US10525005B2
(en)
|
2013-05-23 |
2020-01-07 |
The General Hospital Corporation |
Cromolyn compositions and methods thereof
|
|
US10188757B2
(en)
|
2013-10-22 |
2019-01-29 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
|
PL3104854T3
(pl)
|
2014-02-10 |
2020-11-30 |
Respivant Sciences Gmbh |
Stabilizatory komórek tucznych do leczenia choroby płuc
|
|
EP3653207A1
(en)
|
2014-02-10 |
2020-05-20 |
Respivant Sciences GmbH |
Mast cell stabilizers treatment for systemic disorders
|
|
AU2015350142A1
(en)
|
2014-11-21 |
2017-06-15 |
Biohaven Pharmaceutical Holding Company Ltd. |
Sublingual administration of riluzole
|
|
WO2016196401A1
(en)
|
2015-05-29 |
2016-12-08 |
The Texas A&M University System |
Antimicrobial and anti-inflammatory compositions
|
|
US10265296B2
(en)
|
2015-08-07 |
2019-04-23 |
Respivant Sciences Gmbh |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
|
EP3368032A1
(en)
|
2015-10-28 |
2018-09-05 |
AB Science |
Use of masitinib and other mast cell inhibitors for treatment of parkinson's disease
|
|
CN108472393A
(zh)
|
2015-11-19 |
2018-08-31 |
阿尔茨治疗方法公司 |
用于治疗阿尔茨海默病和有关病症的方法
|
|
EP3380095B1
(en)
|
2015-11-23 |
2022-01-05 |
The General Hospital Corporation |
Compositions and methods for treating ischemic stroke
|
|
AU2017236177B2
(en)
|
2016-03-25 |
2022-03-31 |
Ab Science |
Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation
|
|
US20190240194A1
(en)
|
2016-08-31 |
2019-08-08 |
The General Hospital Corporation |
Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases
|
|
MX2020000577A
(es)
|
2017-07-20 |
2020-09-10 |
Aztherapies Inc |
Formulaciones en polvo de cromolina sodica e ibuprofeno.
|
|
CA3096545A1
(en)
|
2018-04-09 |
2019-10-17 |
The General Hospital Corporation |
Combination therapies for the treatment of amyotropic lateral sclerosis and related disorders
|
|
WO2020010049A1
(en)
|
2018-07-02 |
2020-01-09 |
The General Hospital Corporation |
POWDERED FORMULATIONS OF CROMOLYN SODIUM AND α-LACTOSE
|
|
JP2021535181A
(ja)
|
2018-09-05 |
2021-12-16 |
ザ ジェネラル ホスピタル コーポレイション |
サイトカイン放出症候群を処置する方法
|
|
CN113727736A
(zh)
|
2018-12-10 |
2021-11-30 |
通用医疗公司 |
色甘酸酯及其用途
|
|
JP2023520580A
(ja)
|
2020-04-06 |
2023-05-17 |
ザ ジェネラル ホスピタル コーポレイション |
コロナウイルス誘発炎症状態の処置方法
|
|
IL298673A
(en)
|
2020-06-04 |
2023-01-01 |
Massachusetts Gen Hospital |
Methods for treating the corona virus infection
|